Arvaya Healthcare Limited approves Draft Letter of Offer for ₹205.8 crore Rights Issue
Bijoy Hans · Commercial Services & Supplies
Key highlights
- Rights Issue Committee approved Draft Letter of Offer for partly paid-up equity shares worth ₹20,580 lakhs
- Issue is on a rights basis to eligible equity shareholders as per Companies Act, SEBI ICDR Regulations
- Committee approved application to BSE for in-principle approval of listing the Rights Equity Shares on Nov 06, 2026
Why it's rated notable: the amount is 39% of market value (20% to 50%)
Figures checked against the filing by a second AI read. About the business, not the share price.
Original filing
Outcome Of The Meeting Of The Rights Issue Committee Of The Board Held On Friday, November 06, 2026 - Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Bijoy Hans
- Fundraise / allotmentNotableArvaya Healthcare Limited revises Rights Issue committee authorisation details
- Fundraise / allotmentNotableArvaya Healthcare Limited proposes Rights Issue of Equity Shares up to ₹210 Cr
- Acquisition / mergerNotableArvaya Healthcare Limited completes acquisition of 100% equity of SIGPL
Other fundraise / allotment filings this fortnight
- SML Mahindra Limited announces Board meeting to approve Rights Issue details
- Dev Labtech Venture Limited approves H1 results for half year ended 30 September 2026
- Richa Info Systems approves fundraising of up to ₹50 crore on Nov 6, 2026
- United Van Der Horst approves Q2 results and proposes ₹20 crore preferential issue
- Chaman Metallics Limited files Draft Letter of Offer for Rights Issue on NSE Emerge
- Sigma Advanced Systems Limited announces Board meeting outcomes on Nov 6, 2026
Potential multibaggers · Q2 FY27
Potential multibaggers in Commercial Services & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.